Organisation: Luxembourg Centre for Systems Biomedicine (LCSB)

  • News

    Three Uni.lu professors on the Highly Cited Researchers 2024 list

    Three professors at University of Luxembourg, Michael Heneka, Alexandre Tkatchenko and Paul Wilmes, have been selected on the Highly Cited Researchers 2024 list by Clarivate. A distinction that places them in the top 1% of researchers worldwide, as their highly cited papers rank in the top 1% by citations for their fields and publication year.

    Learn more
  • News

    A quadruple boost to transform knowledge into innovation

    Learn more
  • News

    Luxembourg’s Parkinson’s disease research excellence goes global

    The National Centre of Excellence in Research on Parkinson’s disease joins a prestigious Michael J. Fox Foundation’s research programme.

    Learn more
  • News

    A gut-on-chip device for personalised health solutions

    The University and spin-off NIUM are reinforcing their relationship by signing a second license agreement, through which NIUM will further develop and use MicroGut technology, an in vitro gut-on-a-chip device conceived at University’s Luxembourg Centre for Systems Biomedicine, which emulates the human gastrointestinal tract on a chip, for testing the impact of food products and…

    Learn more
  • Events

    Open Day 2026

    The Open Day invites everyone to delve into the vibrant world of the University. This is a unique opportunity to discover a variety of study programmes and explore our ground-breaking research activities.

    Learn more
  • News

    Three Uni.lu professors on the Highly Cited Researchers 2023 list

    Prof. Michael Heneka, Prof. Alexandre Tkatchenko and Prof. Paul Wilmes have been selected on the Highly Cited Researchers 2023 list by Clarivate, for “demonstrating significant and broad influence in their field(s) of research”.

    Learn more
  • News

    Ground-breaking discovery for diagnosing neurodegenerative diseases

    An international team consisting of researchers from Japan and Luxembourg showed for the first time that pathological forms of the alpha-synuclein protein present in the blood of patients can be used for the diagnosis of Parkinson’s disease and its differentiation from several other neurodegenerative motor disorders.

    Learn more
  • News

    COVID-19 Task Force awarded the 2022 Science for Society Prize

    The 2022 Science for Society Prize, an initiative of the Science for Society Foundation, under the aegis of Fondation de Luxembourg, has been awarded to the Research Luxembourg COVID-19 Task Force, represented by Prof. Paul Wilmes from the University of Luxembourg. The COVID-19 Task Force, a collective effort between several Luxembourg research institutions regrouped under…

    Learn more
  • News

    Gaining unprecedented view of small molecules by machine learning

    A new tool to identify small molecules offers benefits for diagnostics, drug discovery and fundamental research.

    Learn more
  • News

    How damaged cells inhibit muscle regeneration over lifetime

    Humans have a limited capacity for self-regeneration of tissues and organs but they do keep a pool of stem cells throughout their life that can self-renew and differentiate into specific cell types. These stem cells are widely studied as they could enable the repair of human tissues and thus have great potential for medicine. On…

    Learn more